New Delhi, July 2025 — Health-focused VC firm W Health Ventures has announced the launch of its second fund, targeting $70 million (₹585 crore) to invest in early-stage healthtech startups across India and the US. The fund aims to deepen W Health’s commitment to tech-driven healthcare delivery, building on the firm’s previous $30 million Fund I.
Funding Snapshot
- Fund Target: $70 million
- Stage Focus: Seed to Series A
- Geographies: India and United States
- Sector: Digital health, diagnostics, chronic care, AI in healthcare
- Notable Portfolio: BeatO, Fitterfly, Reveal HealthTech, SaveIn, StanPlus
Solving Systemic Health Gaps
W Health Ventures is founded by Sunil Wadhwani, co-founder of Mastech Digital and IGATE. The firm backs startups addressing critical healthcare challenges—access, affordability, and quality of care. In India, this often translates to virtual care delivery, chronic disease management, and AI-powered diagnostics in underserved urban and rural zones.
Their first fund supported over 8 startups, including BeatO (diabetes management), Fitterfly (digital therapeutics), and StanPlus (emergency care).
Fund II Strategy
The new capital will be allocated to startups building virtual-first care models, AI-enabled diagnostic platforms, and scalable mental health or infrastructure solutions. The fund will also look at India–US crossover healthtech opportunities, leveraging dual-market scalability.
Market Watch
India’s digital health market is projected to hit $20 billion by 2030. With increasing investor interest in deep-tech and preventive care, Fund II positions W Health as one of the few healthcare-focused VCs operating across both geographies.
Final Take:
W Health Ventures is doubling down on its thesis technology, clinical depth, and global scalability. For founders tackling India’s toughest healthcare problems, Fund II could be the runway they need to scale impact.